Comments

United Therapeutics

Q: What sector and industry does United Therapeutics (UTHR) operate in?

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

UTHRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$368.11

0.750.20%

Pre-Market: 6:07 AM EDT

Q4 2024 Earnings in 5 days from now on Wed Feb 26th, before the market open

Conference call scheduled in 5 days at 9:00 AM Click to view the webcast

United Therapeutics (UTHR) Forecast

News Earnings United Therapeutics (UTHR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Want to View Edge Rankings?

Unlock The Hidden Results With Your Benzinga Account Now.

Get Started

United Therapeutics (NASDAQ:UTHR) Stock Quotes, Forecast and News Summary

United Therapeutics Stock (NASDAQ: UTHR) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	1.43K / 321.34K
Day Range	- - -
52 Wk Range	213.75 - 417.82
Market Cap	$16.43B
P/E Ratio	16.14
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	5.94%
Days to Cover	6.27

Recent News

Strength Seen in Foghorn Therapeutics: Can Its 9.5% Jump Turn into More Strength?

Foghorn Therapeutics Inc. (NASDAQ: FHTX) shares rallied 9.5% in the last trading session to close at $9.72. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 43.2% gain over the past four weeks.

Zacks

FDA Battles Backlog of Drug Factory Inspections Since COVID-19

FDA faces inspection backlog with serious public health implications, as critical drug manufacturing plants remain unchecked.

Vandana Singh

Ambarella To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Oct 24

Nov 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	1.43K / 321.34K
Day Range	- - -
52 Wk Range	213.75 - 417.82
Market Cap	$16.43B
P/E Ratio	16.14
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	5.94%
Days to Cover	6.27

About United Therapeutics Corp

Sector

Health Care

Industry

Biotechnology

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy United Therapeutics (UTHR) stock?

You can purchase shares of United Therapeutics (NASDAQ:UTHR) through any online brokerage.

View our list of the best stock brokerages

Who are United Therapeutics (UTHR) competitors?

Other companies in United Therapeutics’s space includes: BeiGene (NASDAQ:ONC), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for United Therapeutics (UTHR) stock?

United Therapeutics has a consensus price target of $364.88.

What is the current price for United Therapeutics (UTHR)?

The stock price for United Therapeutics (NASDAQ: UTHR) is $368.11 last updated February 21, 2025 at 6:07 AM EST.

Does United Therapeutics (UTHR) pay a dividend?

There are no upcoming dividends for United Therapeutics.

When is United Therapeutics (NASDAQ:UTHR) reporting earnings?

United Therapeutics’s Q1 earnings are confirmed for Wednesday, April 30, 2025.

Is United Therapeutics (UTHR) going to split?

There is no upcoming split for United Therapeutics.

What sector and industry does United Therapeutics (UTHR) operate in?

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.